Two Sigma Securities »

Cadrenal Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.5k 16k 0.47
2023-09-30 $7.4k 11k 0.68

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Cadrenal Therapeutics

Honkamp Krueger Financial Services
Virtu Financial
Two Sigma Securities
Tower Research Capital

View all funds holding Cadrenal Therapeutics